Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Brain & Spine
|
November 29, 2023
The use of advanced technology for preoperative planning in cranial surgery - A survey by the EANS Young Neurosurgeons Committee
Giovanni Raffa, Toma Spiriev, Cesare Zoia, et al.
Cancers
|
March 25, 2022
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
Johanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, et al.
Brain & Spine
|
October 17, 2022
Laying foundations for the future- establishing the EANS Young Neurosurgeons Network (EANS YNN)
Evangelos Drosos, Cristina C Aldea, Diogo Belo, et al.
Journal of Neuro-Oncology
|
December 30, 2025
Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy
Naureen Keric, Harald Krenzlin, Felipa Lange, et al.
Journal of Neuro-Oncology
|
February 7, 2024
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
Naureen Keric, Harald Krenzlin, Darius Kalasauskas, et al.
Brain & Spine
|
April 26, 2024
The prevalence of imposter syndrome among neurosurgeons in Europe: An EANS YNC survey
Cesare Zoia, Martin N Stienen, Ismail Zaed, et al.
Cancers
|
October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
Johanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Brain & Spine
|
October 17, 2022
Transformation of neurosurgical training from "see one, do one, teach one" to AR/VR & simulation - A survey by the EANS Young Neurosurgeons
Felix C Stengel, Maria L Gandia-Gonzalez, Cristina C Aldea, et al.
Neuro-Oncology
|
March 20, 2024
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticator
Alice Ryba, Zeynep Özdemir, Nitzan Nissimov, et al.
Neuro-Oncology Practice
|
August 7, 2019
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network
Amélie Darlix, Emmanuel Mandonnet, Christian F Freyschlag, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Brain & Spine
|
November 29, 2023
The use of advanced technology for preoperative planning in cranial surgery - A survey by the EANS Young Neurosurgeons Committee
Giovanni Raffa, Toma Spiriev, Cesare Zoia, et al.
Cancers
|
March 25, 2022
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
Johanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, et al.
Brain & Spine
|
October 17, 2022
Laying foundations for the future- establishing the EANS Young Neurosurgeons Network (EANS YNN)
Evangelos Drosos, Cristina C Aldea, Diogo Belo, et al.
Journal of Neuro-Oncology
|
December 30, 2025
Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy
Naureen Keric, Harald Krenzlin, Felipa Lange, et al.
Journal of Neuro-Oncology
|
February 7, 2024
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
Naureen Keric, Harald Krenzlin, Darius Kalasauskas, et al.
Brain & Spine
|
April 26, 2024
The prevalence of imposter syndrome among neurosurgeons in Europe: An EANS YNC survey
Cesare Zoia, Martin N Stienen, Ismail Zaed, et al.
Cancers
|
October 11, 2018
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
Johanna Buchroithner, Friedrich Erhart, Josef Pichler, et al.
Brain & Spine
|
October 17, 2022
Transformation of neurosurgical training from "see one, do one, teach one" to AR/VR & simulation - A survey by the EANS Young Neurosurgeons
Felix C Stengel, Maria L Gandia-Gonzalez, Cristina C Aldea, et al.
Neuro-Oncology
|
March 20, 2024
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticator
Alice Ryba, Zeynep Özdemir, Nitzan Nissimov, et al.
Neuro-Oncology Practice
|
August 7, 2019
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network
Amélie Darlix, Emmanuel Mandonnet, Christian F Freyschlag, et al.
Page
of 9